Nanoform Finland Oyj

Helsinki Stock Exchange NANOFH.HE

Nanoform Finland Oyj EBIT for the year ending December 31, 2023: USD -22.66 M

Nanoform Finland Oyj EBIT is USD -22.66 M for the year ending December 31, 2023, a 2.11% change year over year. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.

Nanoform Finland Oyj EBIT for the year ending December 31, 2022 was USD -23.15 M, a -7.58% change year over year.
Nanoform Finland Oyj EBIT for the year ending December 31, 2021 was USD -21.52 M, a 8.06% change year over year.
Nanoform Finland Oyj EBIT for the year ending December 31, 2020 was USD -23.41 M, a -182.49% change year over year.
Nanoform Finland Oyj EBIT for the year ending December 31, 2019 was USD -8.29 M, a -264.16% change year over year.

Key data

Date	EBIT	EBITDA	Net Income	EPS (Diluted)

Helsinki Stock Exchange: NANOFH.HE

Nanoform Finland Oyj

CEO	Prof. Edward Olof Haeggstrom
IPO Date	June 4, 2020
Location	Finland
Headquarters	Cultivator II
Employees	174
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Engineering Services

Description

Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.

Key trends

Past 5 years